Kabir Nigam, Kimberly A. Curseen, Yvan Beaussant, Clinics in Geriatric Medicine This review article discusses the potential of psychedelics, related pharmacotherapies as integrative medicine for older adults in palliative care. It explores the use of these substances in addressing existential distress, serious illness, end-of-life care, highlighting the need for further research, consideration of psychedelic-assisted therapy…
Pressing regulatory challenges for psychedelic medicine
Amy L. McGuire, Holly Fernandez Lynch, Lewis A. Grossman,, I. Glenn Cohen; Science This article discusses the regulatory challenges faced in the development of psychedelic medicine. It highlights the growing interest, investment in psychedelic drug development, the complexities of applying traditional clinical trial, premarket approval processes to these substances. The article emphasizes the need for…
Pharmacotherapy, Ketamine Assisted Psychotherapy for Treatment-Resistant Depression: A Patient With Lifelong Self-Doubt, Self-Criticism
Albert Yeung, Guy Sapirstein, Laura D. Crain, Margaret A. Cramer, Fernando Espi Forcen, Susan Sprich, Jonah N. Cohen; The Journal of Clinical Psychiatry This article discusses a case of treatment-resistant depression (TRD) in a 61-year-old patient named John, who had a long history of depression, inadequate responses to various treatments, including medications, therapy. The article…